Sep 17 |
BioLineRx Launches 'Mobilization Matters': A Digital Resource for People with Multiple Myeloma Preparing for Stem Cell Collection
|
Aug 20 |
BLRX: On Track for 60% Formulary Placement
|
Aug 15 |
BioLineRx Ltd. (BLRX) Q2 2024 Earnings Call Transcript
|
Aug 15 |
BioLineRx GAAP EPS of $0.00, revenue of $5.39M
|
Aug 15 |
BioLineRx Reports Second Quarter 2024 Financial Results and Recent Corporate and Portfolio Updates
|
Aug 14 |
biolinerx Q2 Earnings Preview
|
Aug 8 |
BioLineRx to Report Second Quarter 2024 Results on August 15, 2024
|
Jun 10 |
BLRX: First Quarter 2024 Results
|
Jun 5 |
Millionaire Makers: 7 Stocks You Can Buy for $2 That Can 10X by 2025
|
May 30 |
BioLineRx stock jumps 14% on St. Jude clinical trial for mitoxafortide
|